Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Hepatol. Apr 27, 2013; 5(4): 206-213
Published online Apr 27, 2013. doi: 10.4254/wjh.v5.i4.206
Figure 4
Figure 4 Hepatic apurinic/apyrimidinic endonuclease 1 mRNA expression in patients with chronic liver disease. Real-time polymerase chain reaction (PCR) analysis showed that apurinic/apyrimidinic endonuclease 1 (APE-1) mRNA levels were reduced by 58% in HBV livers compared with HCV livers (aP < 0.05 vs HCV).